Long-term Outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia. Guilhot F, Hehlmann R. Blood 2024 Nov 1:blood.2024026311. doi: 10.1182/blood.2024026311.

Read + Share

Amedeo Smart

Independent Medical Education

Guilhot F, Hehlmann R. Long-term Outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia. Blood 2024 Nov 1:blood.2024026311. doi: 10.1182/blood.2024026311.
PMID: 39486043